AR and COVID-19: Accordingly, the reduction of the TMPRSS2 expression by blocking the androgen receptor would decrease SARS-CoV-2 entry into human cells [6-8, 13-17], which is corroborated by studies showing protection from more severe states related to COVID-19 with the use of antiandrogens [6-8].